• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

由前列腺特异性抗原裂解的白蛋白结合阿霉素前药的开发。

Development of albumin-binding doxorubicin prodrugs that are cleaved by prostate-specific antigen.

作者信息

Kratz Felix, Mansour Ahmed, Soltau Jens, Warnecke Andre, Fichtner Iduna, Unger Clemens, Drevs Joachim

机构信息

Tumor Biology Center, Freiburg, Germany.

出版信息

Arch Pharm (Weinheim). 2005 Oct;338(10):462-72. doi: 10.1002/ardp.200500130.

DOI:10.1002/ardp.200500130
PMID:16211657
Abstract

Prostate-specific antigen (PSA) is a serine protease that is overexpressed in prostate carcinoma and represents a molecular target for selectively releasing an anticancer agent from a prodrug formulation. In this work, we developed albumin-binding prodrugs with the structures MT-Ser-Ser-Tyr-Tyr- Ser-Gly-DOXO, MT-Asn-Ser-Ser-Tyr-Phe-Gln-DOXO (MT = maleimidotriethyleneglycol acid; DOXO = Doxorubicin) or EMC-Arg-Arg-Ser-Ser-Tyr-Tyr-Ser-Gly-DOXO (EMC = epsilon-maleimidocaproic acid; X = amino acid). The maleimide Doxorubicin derivatives bound rapidly to the cysteine-34 position of endogenous and exogenous albumin and were efficiently cleaved by PSA at the P(1)-P'(1) scissile bond, releasing a respective Doxorubicin dipeptide (Ser-Gly-DOXO or Phe-Gln-DOXO). The derivative containing arginine residues (EMC-Arg-Arg-Ser-Ser-Tyr-Tyr-Ser-Gly-DOXO) exhibited excellent water solubility for intravenous administration. Subsequent biological evaluation was focused on a PSA-negative xenograft model (PC 3) and a PSA-positive xenograft model (CWR22) in order to assess the selectivity of our therapeutic approach. EMC-Arg-Arg-Ser-Ser-Tyr-Tyr-Ser-Gly-DOXO showed no in vivo activity in the PSA-negative PC 3 model, but good activity in the CWR22 PSA-positive model that was comparable to Doxorubicin.

摘要

前列腺特异性抗原(PSA)是一种丝氨酸蛋白酶,在前列腺癌中过表达,是从前药制剂中选择性释放抗癌剂的分子靶点。在这项工作中,我们开发了具有MT-Ser-Ser-Tyr-Tyr-Ser-Gly-DOXO、MT-Asn-Ser-Ser-Tyr-Phe-Gln-DOXO(MT = 马来酰亚胺三甘醇酸;DOXO = 多柔比星)或EMC-Arg-Arg-Ser-Ser-Tyr-Tyr-Ser-Gly-DOXO(EMC = ε-马来酰亚胺己酸;X = 氨基酸)结构的白蛋白结合前药。马来酰亚胺多柔比星衍生物迅速与内源性和外源性白蛋白的半胱氨酸-34位点结合,并被PSA在P(1)-P'(1)可裂解键处有效切割,释放出相应的多柔比星二肽(Ser-Gly-DOXO或Phe-Gln-DOXO)。含有精氨酸残基的衍生物(EMC-Arg-Arg-Ser-Ser-Tyr-Tyr-Ser-Gly-DOXO)表现出优异的水溶性,适合静脉给药。随后的生物学评估集中在PSA阴性异种移植模型(PC 3)和PSA阳性异种移植模型(CWR22)上,以评估我们治疗方法的选择性。EMC-Arg-Arg-Ser-Ser-Tyr-Tyr-Ser-Gly-DOXO在PSA阴性的PC 3模型中没有体内活性,但在CWR22 PSA阳性模型中具有良好的活性,与多柔比星相当。

相似文献

1
Development of albumin-binding doxorubicin prodrugs that are cleaved by prostate-specific antigen.由前列腺特异性抗原裂解的白蛋白结合阿霉素前药的开发。
Arch Pharm (Weinheim). 2005 Oct;338(10):462-72. doi: 10.1002/ardp.200500130.
2
Synthesis and biological evaluation of an albumin-binding prodrug of doxorubicin that is cleaved by prostate-specific antigen (PSA) in a PSA-positive orthotopic prostate carcinoma model (LNCaP).在前列腺特异性抗原(PSA)阳性原位前列腺癌模型(LNCaP)中被PSA裂解的阿霉素白蛋白结合前药的合成及生物学评价
Int J Cancer. 2008 Mar 1;122(5):1145-54. doi: 10.1002/ijc.23050.
3
Albumin-binding prodrugs of camptothecin and doxorubicin with an Ala-Leu-Ala-Leu-linker that are cleaved by cathepsin B: synthesis and antitumor efficacy.具有丙氨酸-亮氨酸-丙氨酸-亮氨酸连接子、可被组织蛋白酶B裂解的喜树碱和阿霉素白蛋白结合前药:合成与抗肿瘤疗效
Bioconjug Chem. 2007 May-Jun;18(3):702-16. doi: 10.1021/bc0602735. Epub 2007 Mar 23.
4
In vivo evaluation of a novel albumin-binding prodrug of doxorubicin in an orthotopic mouse model of prostate cancer (LNCaP).在前列腺癌(LNCaP)原位小鼠模型中对新型阿霉素白蛋白结合前药的体内评价。
Prostate Cancer Prostatic Dis. 2011 Mar;14(1):14-21. doi: 10.1038/pcan.2010.43. Epub 2010 Nov 2.
5
Development of a novel prodrug of paclitaxel that is cleaved by prostate-specific antigen: an in vitro and in vivo evaluation study.开发一种新型的紫杉醇前药,该前药可被前列腺特异性抗原切割:体外和体内评价研究。
Eur J Cancer. 2010 Dec;46(18):3434-44. doi: 10.1016/j.ejca.2010.08.018.
6
A new approach for the treatment of malignant melanoma: enhanced antitumor efficacy of an albumin-binding doxorubicin prodrug that is cleaved by matrix metalloproteinase 2.一种治疗恶性黑色素瘤的新方法:基质金属蛋白酶2裂解的白蛋白结合阿霉素前药增强抗肿瘤疗效
Cancer Res. 2003 Jul 15;63(14):4062-6.
7
Enzymatic activation of a doxorubicin-peptide prodrug by prostate-specific antigen.前列腺特异性抗原对阿霉素-肽前药的酶促激活作用。
Cancer Res. 1998 Jun 15;58(12):2537-40.
8
Development of albumin-binding camptothecin prodrugs using a Peptide positional scanning library.利用肽位置扫描文库开发白蛋白结合喜树碱前药
Bioconjug Chem. 2007 Nov-Dec;18(6):1786-99. doi: 10.1021/bc0700842. Epub 2007 Oct 5.
9
Development of a novel albumin-binding prodrug that is cleaved by urokinase-type-plasminogen activator (uPA).一种新型白蛋白结合前药的研发,该前药可被尿激酶型纤溶酶原激活剂(uPA)裂解。
Bioorg Med Chem Lett. 2006 Oct 1;16(19):5157-63. doi: 10.1016/j.bmcl.2006.07.023. Epub 2006 Jul 27.
10
PSA-specific and non-PSA-specific conversion of a PSA-targeted peptide conjugate of doxorubicin to its active metabolites.阿霉素的PSA靶向肽缀合物向其活性代谢物的PSA特异性和非PSA特异性转化。
Drug Metab Dispos. 2001 Mar;29(3):313-8.

引用本文的文献

1
Improved Targeting and Safety of Doxorubicin through a Novel Albumin Binding Prodrug Approach.通过一种新型白蛋白结合前药方法提高阿霉素的靶向性和安全性。
ACS Omega. 2023 Dec 21;9(1):977-987. doi: 10.1021/acsomega.3c07163. eCollection 2024 Jan 9.
2
The Release of a Highly Cytotoxic Paullone Bearing a TEMPO Free Radical from the HSA Hydrogel: An EPR Spectroscopic Characterization.从人血清白蛋白水凝胶中释放出带有TEMPO自由基的高细胞毒性保罗酮:电子顺磁共振波谱表征
Pharmaceutics. 2022 May 30;14(6):1174. doi: 10.3390/pharmaceutics14061174.
3
Emerging Albumin-Binding Anticancer Drugs for Tumor-Targeted Drug Delivery: Current Understandings and Clinical Translation.
用于肿瘤靶向给药的新型白蛋白结合抗癌药物:现状与临床转化
Pharmaceutics. 2022 Mar 28;14(4):728. doi: 10.3390/pharmaceutics14040728.
4
Therapeutic potential of an anti-HER2 single chain antibody-DM1 conjugates for the treatment of HER2-positive cancer.抗 HER2 单链抗体-DM1 偶联物治疗 HER2 阳性癌症的治疗潜力。
Signal Transduct Target Ther. 2017 May 19;2:17015. doi: 10.1038/sigtrans.2017.15. eCollection 2017.
5
Simple bioconjugate chemistry serves great clinical advances: albumin as a versatile platform for diagnosis and precision therapy.简单的生物共轭化学推动了重大的临床进展:白蛋白作为诊断和精准治疗的通用平台。
Chem Soc Rev. 2016 Mar 7;45(5):1432-56. doi: 10.1039/c5cs00158g.
6
Optimization of an albumin-binding prodrug of Doxorubicin that is cleaved by prostate-specific antigen.一种由前列腺特异性抗原裂解的阿霉素白蛋白结合前药的优化。
ACS Med Chem Lett. 2010 May 26;1(5):234-8. doi: 10.1021/ml100060m. eCollection 2010 Aug 12.
7
Protease-activated drug development.蛋白酶激活药物研发。
Theranostics. 2012;2(2):156-78. doi: 10.7150/thno.4068. Epub 2012 Feb 8.
8
Potential of amino acid/dipeptide monoester prodrugs of floxuridine in facilitating enhanced delivery of active drug to interior sites of tumors: a two-tier monolayer in vitro study.氟尿苷氨基酸/二肽单酯前药提高活性药物向肿瘤内部传递的潜力:双层单层体外研究。
Pharm Res. 2011 Oct;28(10):2575-88. doi: 10.1007/s11095-011-0485-7. Epub 2011 Jun 14.